Opioid receptor
From Proteopedia
(Difference between revisions)
| (9 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
<StructureSection load='' size='350' side='right' caption='Structure of κ-opioid receptor complex with opioid antagonist, citric acid, PEG and octadec-enoate derivative (PDB entry [[4djh]])' scene='55/553941/Cv/1' pspeed='8'> | <StructureSection load='' size='350' side='right' caption='Structure of κ-opioid receptor complex with opioid antagonist, citric acid, PEG and octadec-enoate derivative (PDB entry [[4djh]])' scene='55/553941/Cv/1' pspeed='8'> | ||
== Function == | == Function == | ||
| - | '''Opioid receptor''' (OpR) is a G protein-coupled receptor with [[opioids]] as ligands<ref>PMID:22204322</ref>. OpR types are classified according to the ligands which bind to them.<br /> | + | '''Opioid receptor''' (OpR) is a [[G protein-coupled receptor]] with [[opioids]] as ligands<ref>PMID:22204322</ref>. OpR types are classified according to the ligands which bind to them.<br /> |
* The '''μ-opioid receptor''' binds morphine. For more details on μ-opioid receptor see<br /> | * The '''μ-opioid receptor''' binds morphine. For more details on μ-opioid receptor see<br /> | ||
**[[Mu Opioid Receptor Bound to a Morphinan Antagonist]] | **[[Mu Opioid Receptor Bound to a Morphinan Antagonist]] | ||
| + | **[[Kratom]] | ||
**[[μ Opioid Receptors]] | **[[μ Opioid Receptors]] | ||
| - | **[[Mu Opioid Receptor]] | + | **[[Mu Opioid Receptor]] |
| + | **[[Antagonists]] | ||
**[[6dde]] μ-opioid receptor: G protein complex<br /> | **[[6dde]] μ-opioid receptor: G protein complex<br /> | ||
* The '''κ-opioid receptor''' binds opium-type ligands. For details see [[Student Project 3 for UMass Chemistry 423 Spring 2015]].<br /> | * The '''κ-opioid receptor''' binds opium-type ligands. For details see [[Student Project 3 for UMass Chemistry 423 Spring 2015]].<br /> | ||
| Line 12: | Line 14: | ||
See also | See also | ||
| - | *[Opioids]] | + | *[[Opioids]] |
| + | *[[Opioid receptors]] | ||
*[[Treatments:Opioid drugs]] | *[[Treatments:Opioid drugs]] | ||
*[[Tutorial: The opioid receptor, a molecular switch]] | *[[Tutorial: The opioid receptor, a molecular switch]] | ||
| + | *[[Transmembrane (cell surface) receptors]] | ||
== Relevance == | == Relevance == | ||
| Line 32: | Line 36: | ||
**[[4ej4]] – mOpR + naltrindole - mouse <br /> | **[[4ej4]] – mOpR + naltrindole - mouse <br /> | ||
| + | **[[6pt2]] – hOpR + peptide antagonist - human <br /> | ||
| + | **[[6pt3]] – hOpR + antagonist <br /> | ||
| + | **[[8f7s]] – hOpR + GI + deltorphin – Cryo EM <br /> | ||
| - | *κ-opioid receptor | + | *κ-opioid receptor |
| - | **[[4djh]] – hOpR + opioid antagonist | + | **[[4djh]] – hOpR + opioid antagonist<br /> |
| + | **[[6vi4]] – hOpR (mutant) + nanobody<br /> | ||
| + | **[[7yit]] – hOpR (mutant) + nanobody + cytochrome b562<br /> | ||
| + | **[[7y1f]] – hOpR + GI + nanobody + dynorphin peptide – Cryo EM <br /> | ||
| + | **[[8dzr]] – hOpR (mutant`) + GI + nanobody + gustucin peptide – Cryo EM <br /> | ||
| + | **[[8dzp]], [[8dzs]] – hOpR (mutant`) + GI + nanobody + ligand – Cryo EM <br /> | ||
| - | *Nociceptin/orphanin FQ opioid receptor | + | *Nociceptin/orphanin FQ opioid receptor |
**[[4ea3]] – hOpR + peptide mimetic <br /> | **[[4ea3]] – hOpR + peptide mimetic <br /> | ||
| + | **[[8f7w]], [[8f7x]] – hOpR + GI + nanobody + nociceptin peptide – Cryo EM <br /> | ||
| - | *μ-opioid receptor | + | *μ-opioid receptor |
| + | |||
| + | **[[8efq]] – hOpR + GI + DAMGO peptide – Cryo EM <br /> | ||
| + | **[[8f7r]] – hOpR + GI + nanobody + endomorphin peptide – Cryo EM <br /> | ||
| + | **[[8f7q]] – hOpR + GI + nanobody + endorphin peptide – Cryo EM <br /> | ||
| + | **[[8ef6]] – hOpR + GI + nanobody + morphin – Cryo EM <br /> | ||
| + | **[[7t2h]], [[7u2k]], [[8ef5]], [[8efb]], [[8efl]], [[8efo]] – hOpR + GI + nanobody + drug – Cryo EM <br /> | ||
| + | **[[4dkl]], [[5c1m]] – mOpR + opioid antagonist <br /> | ||
| + | **[[6ddf]] – mOpR + GI + DAMGO peptide – Cryo EM <br /> | ||
| + | **[[7u2l]] – mOpR + GI + nanobody – Cryo EM <br /> | ||
| + | **[[6dde]] – mOpR + GI + nanobody + DAMGO peptide – Cryo EM <br /> | ||
| + | **[[7t2g]] – mOpR + GI + antagonist – Cryo EM <br /> | ||
| + | **[[7scg]] – mOpR + GI + nanobody + antagonist – Cryo EM <br /> | ||
| + | **[[7ul4]] – mOpR + megabody + drug – Cryo EM <br /> | ||
| - | **[[4dkl]] – mOpR + opioid antagonist <br /> | ||
| - | **[[5c1m]] – mOpR + opioid angonist <br /> | ||
}} | }} | ||
Current revision
| |||||||||||
3D structures of opioid receptor
Updated on 20-August-2023
References
- ↑ Feng Y, He X, Yang Y, Chao D, Lazarus LH, Xia Y. Current research on opioid receptor function. Curr Drug Targets. 2012 Feb;13(2):230-46. PMID:22204322
- ↑ Donica CL, Awwad HO, Thakker DR, Standifer KM. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ. Mol Pharmacol. 2013 May;83(5):907-18. doi: 10.1124/mol.112.084632. Epub 2013 Feb , 8. PMID:23395957 doi:http://dx.doi.org/10.1124/mol.112.084632
- ↑ Zaveri NT. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications. Curr Top Med Chem. 2011;11(9):1151-6. PMID:21050175
- ↑ Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr Drug Targets. 2007 Jan;8(1):117-35. PMID:17266536
- ↑ Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC. Structure of the human kappa-opioid receptor in complex with JDTic. Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939. PMID:22437504 doi:10.1038/nature10939
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Karsten Theis, Joel L. Sussman
